Focus Partners Wealth increased its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 17.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 288,112 shares of the conglomerate’s stock after buying an additional 42,286 shares during the period. Focus Partners Wealth’s holdings in Danaher were worth $57,576,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of DHR. Tyche Wealth Partners LLC bought a new position in shares of Danaher in the third quarter worth about $462,000. Ceredex Value Advisors LLC boosted its stake in Danaher by 1.6% during the 2nd quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock valued at $49,262,000 after purchasing an additional 3,862 shares during the period. Weitz Investment Management Inc. grew its holdings in Danaher by 6.1% in the 2nd quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock valued at $104,094,000 after buying an additional 30,300 shares during the last quarter. Lockheed Martin Investment Management Co. increased its position in Danaher by 49.4% in the 3rd quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock worth $5,024,000 after buying an additional 8,380 shares during the period. Finally, Johnson Investment Counsel Inc. lifted its holdings in shares of Danaher by 2.9% during the third quarter. Johnson Investment Counsel Inc. now owns 664,705 shares of the conglomerate’s stock worth $131,784,000 after buying an additional 18,744 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Danaher
In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.20% of the stock is owned by company insiders.
Danaher Stock Up 2.2%
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same quarter in the previous year, the firm posted $2.14 EPS. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s payout ratio is presently 25.40%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on DHR shares. Evercore reissued an “outperform” rating and issued a $254.00 price objective on shares of Danaher in a research report on Wednesday, January 28th. Leerink Partners upped their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Wells Fargo & Company increased their price target on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $253.55.
Get Our Latest Research Report on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
